EGFR inhibitor
N-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide
Molecular Identity
EGFR inhibitor
N-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide
PubChem CID: 9549299
2D Structure
Properties
C21H18F3N5O
Molecular Formula
413.40
Molecular Weight
g/mol
413.1463
Exact Mass
Da
4.5
XLogP
Drug-like (Lipinski: < 5)
78.9
TPSA
Good oral absorption (< 140 A²)
3
H-Bond Donors
8
H-Bond Acceptors
585
Complexity
SMILES
Canonical SMILES
SMILES: C1CC1C(=O)NC2=CC=CC(=C2)NC3=NC=NC(=C3)NC4=CC=CC(=C4)C(F)(F)FIsomeric SMILES
SMILES: C1CC1C(=O)NC2=CC=CC(=C2)NC3=NC=NC(=C3)NC4=CC=CC(=C4)C(F)(F)FSynonyms(20)
EGFR Inhibitor879127-07-8N-(3-((6-((3-(Trifluoromethyl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)cyclopropanecarboxamideDTXSID40429554N-{3-[(6-{[3-(trifluoromethyl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}cyclopropanecarboxamideN-[3-[[6-[[3-(trifluoromethyl)phenyl]amino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamideEGFR BlockerEGFR-TK InhibitorRefChem:136350EGFR Tyrosine Kinase InhibitorEGFR Tyrosine Kinase InhibitorsDTXCID30380387Epidermal Growth Factor Receptor InhibitorEpidermal Growth-Factor Receptor InhibitorsEPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITOR
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to EGFR inhibitor
Loading drug network...